Point72 Asset Management, L.P. 13D and 13G filings for Chinook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:12 pm Sale | 2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY | Point72 Asset Management, L.P. | 1,299,548 2.000% | -1,817,932 (-58.31%) | Filing |
| 2022-06-07 4:45 pm Purchase | 2022-05-27 | 13G | Chinook Therapeutics, Inc. KDNY | Point72 Asset Management, L.P. | 3,117,480 5.100% | 3,117,480 (New Position) | Filing |